Skip to main navigation
Flexion

New paradigms for the treatment of pain

COVID-19 Update
  • Who We Are
    • Executive Committee
    • Board of Directors
    • Core Principles & Values
    • Corporate Social Responsibility
  • Our Product
  • Our Pipeline
    • FX201
    • FX301
  • Our Science
    • Unmet Need in Osteoarthritis
    • Clinical Trials and Associated Publications
  • News
    • Press Releases
  • Investors

    Investor Relations

    • Investors
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
      • Quarterly Results
      • Key Ratios
    • Stock Information
    • Analyst Coverage
    • Contact Us
  • Careers
    • Current Openings
    • Benefits and Incentives
    • Our Culture
  • Contact
    • Partnering
    • Medical Information Request Form
    • Investigator-Initiated Research
    • Medical Education/ Corporate Grants

Financials & Filings

Show all

2021

First Quarter
  • Flexion Therapeutics Announces Preliminary First-Quarter 2021 Revenue and Provides Financial Guidance for 2021

Annual Reports

Documents
  • Add Files
    2019 Annual Report 11.8 MB
  • Add Files
    2018 Annual Report 8.4 MB

Proxy Statements

Filing date View
Apr 29, 2020 View HTML
0001564590-20-019691.pdf
0001564590-20-019691.rtf
0001564590-20-019691.xls
Apr 26, 2019 View HTML
0001564590-19-013344.pdf
0001564590-19-013344.rtf
0001564590-19-013344.xls

Form 10-K

Filing date View
Mar 10, 2021 View HTML
0001564590-21-012050.pdf
0001564590-21-012050.rtf
0001564590-21-012050.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 12, 2020 View HTML
0001564590-20-010490.pdf
0001564590-20-010490.rtf
0001564590-20-010490.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Form 10-Q

Filing date View
Nov 04, 2020 View HTML
0001564590-20-050458.pdf
0001564590-20-050458.rtf
0001564590-20-050458.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 05, 2020 View HTML
0001564590-20-036837.pdf
0001564590-20-036837.rtf
0001564590-20-036837.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 07, 2020 View HTML
0001564590-20-022827.pdf
0001564590-20-022827.rtf
0001564590-20-022827.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Investor Relations

  • Investors
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
    • SEC Filings
    • Annual Reports and Proxies
    • Quarterly Results
    • Key Ratios
  • Stock Information
  • Analyst Coverage
  • Contact Us

Shareholder Tools

Printed Materials
Email Alerts
RSS
Print
Share
:
Day High:
Day Low:
Volume:

Data Provided by Refinitiv. Minimum 15 minutes delayed.


© 2021, Flexion Therapeutics, Inc.

781.305.7777

Website Design & Development by Graphic Beans

Terms of Use Sitemap Privacy Policy

Connect with us: LinkedIn-whiteTwitter-whiteGlassdoor-white